Non-muscle invasive urothelial bladder cancer in a 17-year-old male: A rare case report

被引:0
作者
Hmaidy, Osama [1 ]
Jamal, Bakri Roumi [2 ]
Mayo, Mohammed [2 ]
Haidar, Mariam [3 ]
Horan, Mohammad [4 ]
Alsayed-Ahmad, Zein A. [2 ]
机构
[1] Damascus Univ, Fac Med, Dept Urol Surg, Damascus, Syria
[2] Aleppo Univ, Fac Med, Aleppo, Syria
[3] Damascus Univ, Fac Med, Dept Pathol, Damascus, Syria
[4] NMC ROYAL HOSP SHARJAH, Dept Urol, NMC Healthcare, Sharjah, U Arab Emirates
来源
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS | 2023年 / 110卷
关键词
Case report; Urothelial bladder cancer; TURBT; NMIBC; Cystoscopy; Hematuria; TRANSITIONAL-CELL-CARCINOMA; CHILDREN;
D O I
10.1016/j.ijscr.2023.108728
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction and importance: Urothelial carcinoma of the bladder predominantly affects adults with rare cases in young patients. This manuscript presents a rare case of urothelial carcinoma highlighting clinical characteristics, diagnosis, treatment, and prognosis in this age group. Our aim is to raise awareness among healthcare professionals for improved outcomes in children and adolescents with bladder urothelial carcinoma.Case presentation: A 17-year-old male presented with hematuria and urinary symptoms. No history of smoking, alcohol, surgeries, family conditions, or medications. The patient had environmental chemical exposure near an oil refinery. An initial ultrasound and Cystoscopy showed a sizable bladder tumor. A complete TURBT was done, followed by cauterization and catheter placement. The tumor was diagnosed as low-grade urothelial carcinoma (pT1). Follow-up cystoscopies after 3 and 9 months showed no recurrence.Clinical discussion: Urothelial bladder carcinoma (UBC) is linked to occupational exposure and smoking. Limited research exists on UBC in young patients, but genetic factors and environmental exposure may play a role. In young individuals, UBC typically presents as low-grade, non-muscle invasive tumors (NMIBC). Transurethral resection may be sufficient for low-grade tumors, and postoperative follow-up with ultrasound is important. Larger tumors have a higher risk of recurrence and progression. Conclusion: The present case emphasizes the need to consider urothelial bladder carcinoma as a potential cause of hematuria in young patients and conduct a thorough evaluation of all risk factors. Future research is needed to establish evidence-based guidelines for managing this condition in pediatric and adolescent patients.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Immunotherapies in non-muscle invasive bladder cancer: immunotherapies and NMIBC
    Loriot, Yohann
    Roupret, Morgan
    BULLETIN DU CANCER, 2020, 107 (05) : S49 - S55
  • [32] Are we following the guidelines on non-muscle invasive bladder cancer?
    Reis, Leonardo Oliveira
    Moro, Juliano Cesar
    Bastos Ribeiro, Luis Fernando
    Iamashita Voris, Brunno Raphael
    Sadi, Marcos Vinicius
    INTERNATIONAL BRAZ J UROL, 2016, 42 (01): : 22 - 28
  • [33] Emerging treatment landscape of non-muscle invasive bladder cancer
    Valenza, Carmine
    Antonarelli, Gabriele
    Giugliano, Federica
    Aurilio, Gaetano
    Verri, Elena
    Briganti, Alberto
    Curigliano, Giuseppe
    Necchi, Andrea
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (06) : 717 - 734
  • [34] Perfusion drugs for non-muscle invasive bladder cancer (Review)
    Qian, Jingyuan
    Zhang, Qiuchen
    Cao, Yang
    Chu, Xi
    Gao, Yiyang
    Xu, Haifei
    Cai, Hongzhou
    Wu, Jiajia
    ONCOLOGY LETTERS, 2024, 27 (06)
  • [35] Current intravesical therapy for non-muscle invasive bladder cancer
    van Lingen, Anna V.
    Witjes, J. Alfred
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (10) : 1371 - 1385
  • [36] Non-muscle invasive bladder cancer biomarkers beyond morphology
    De Carlo, Camilla
    Valeri, Marina
    Corbitt, Devin Nicole
    Cieri, Miriam
    Colombo, Piergiuseppe
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] The role of hyperthermia as a treatment for non-muscle invasive bladder cancer
    Bahouth, Zaher
    Halachmi, Sarel
    Moskovitz, Boaz
    Nativ, Ofer
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (02) : 189 - 198
  • [38] The role of pelvic lymphadenectomy in non-muscle invasive bladder cancer
    Lin, James
    Deibert, Christopher M.
    Holder, Dara
    Benson, Mitchell C.
    McKiernan, James M.
    CANADIAN JOURNAL OF UROLOGY, 2014, 21 (01) : 7108 - 7113
  • [39] Active Surveillance in Non-Muscle Invasive Bladder Cancer, the Potential Role of Biomarkers: A Systematic Review
    Parrao, Diego
    Lizana, Nemecio
    Saavedra, Catalina
    Larranaga, Matias
    Lindsay, Carolina B.
    San Francisco, Ignacio F.
    Bravo, Juan Cristobal
    CURRENT ONCOLOGY, 2024, 31 (04) : 2201 - 2220
  • [40] CUA guidelines on the management of non-muscle invasive bladder cancer
    Kassouf, Wassim
    Traboulsi, Samer L.
    Kulkarni, Girish S.
    Breau, Rodney H.
    Zlotta, Alexandre
    Fairey, Andrew
    So, Alan
    Lacombe, Louis
    Rendon, Ricardo
    Aprikian, Armen G.
    Siemens, D. Robert
    Izawa, Jonathan I.
    Black, Peter
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (9-10): : E690 - E704